CRSP

Crispr Therapeutics AG (CRSP)

US
$ 37.531.46%

Price Chart

Key Statistics

Market Cap
$ 4.91B
P/E Ratio
0.00
Revenue (TTM)
$ 37.68M
Volume
1.29M
52W High
$ 63.68
52W Low
$ 30.04
Dividend Yield
0.00%
Beta
1.74

Technicals

50-Day MA
42.1455
200-Day MA
43.3967
52 Week High
63.68
52 Week Low
30.04

About CRSP

CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious human diseases using its Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISP.

Employees
393
Headquarters
Zug, Switzerland
CEO
Dr. Samarth Kulkarni Ph.D.

Latest News

Advanced Charts

Access professional-grade trading charts and technical analysis tools

Top Gainers

Symbol/Name
LTP
% Chg
JELD
JELD-WEN Holding In...
$ 4.40
12.24
LVS
Las Vegas Sands Cor...
$ 47.36
8.87
CCS
Century Communities...
$ 61.22
8.70
KTB
Kontoor Brands Inc....
$ 71.65
8.61
BBWI
Bath & Body Works I...
$ 32.40
8.14

Top Losers

Symbol/Name
LTP
% Chg
ACHR
Archer Aviation Inc...
$ 9.97
-8.11
AMC
AMC Entertainment H...
$ 2.87
-7.42
OKLO
Oklo Inc.
$ 52.29
-6.58
QS
QuantumScape Corpor...
$ 6.29
-6.40
SE
Sea Limited America...
$ 150.49
-5.96